Nanjing Vcare Approved to Establish Jiangsu Provincial Postdoctoral Innovation Practice Base

2026-01-06

　　Recently, the Jiangsu Provincial Department of Human Resources and Social Security released the list of newly approved postdoctoral innovation practice bases for 2025. Nanjing Vcare PharmaTech Co., Ltd. (Nanjing Vcare) has been officially approved to set up a Jiangsu Provincial Postdoctoral Innovation Practice Base, relying on its strong R&D and innovation strengths as well as a comprehensive talent training system. The establishment of this provincial high-end talent platform marks a crucial step for Nanjing Vcare in introducing and cultivating high-caliber talents and building an innovation system featuring in-depth integration of industry, academia, research and application, injecting new driving forces for the high-quality development of the company and the regional biopharmaceutical industry.

 

　　Adhering to the philosophy that "talents are the primary resource", Nanjing Vcare has built a well-structured and highly professional talent team. It currently has over 800 employees, among whom master’s degree holders and above account for more than 40%, and professional technical personnel exceed 84%, forming an innovation-driven pattern led by high-end talents and supported by professional teams. The company boasts 16 PhDs in the core team, including 4 Jiangsu Provincial "Double Innovation PhDs". This experienced core team serves as a valuable asset for the company’s sustained innovation. Supported by a solid talent foundation, Nanjing Vcare has achieved fruitful R&D innovations: it has filed a total of 51 domestic and overseas invention patent applications, obtained 14 authorized invention patents, and realized the industrial transformation of multiple achievements.

 

　　As an important provincial platform for postdoctoral work, the Jiangsu Provincial Postdoctoral Innovation Practice Base acts as a core carrier for high-end talent cultivation, scientific and technological innovation, and achievement transformation. It aims to promote joint recruitment and training of postdoctoral talents by enterprises, universities and research institutions, facilitate the sharing mechanism of top talents, and enhance enterprises’ core competitiveness and technological capabilities.

 

　　Focusing on building a talent gathering highland and a pharmaceutical R&D innovation platform, Nanjing Vcare will strengthen in-depth industry-university-research integration around cutting-edge pharmaceutical R&D fields such as new quality productive forces, green chemistry, synthetic biology, and AI technology application, and develop a batch of landmark research achievements with strategic guidance and practical value. This initiative will further connect the transformation pathway from basic research to industrial application, promote high-level collaborative innovation between industry, academia and research, and accelerate the conversion of scientific and technological achievements into real productive forces. Looking ahead, through the operation of the base, Nanjing Vcare will foster its internal core competitiveness and contribute key strength to building a more dynamic regional biopharmaceutical innovation community.

Next

Only Three in Nanjing! Nanjing Vcare’s Full-industry-chain Pilot Platform for Drug R&D Shortlisted in the 2025 Provincial Manufacturing Pilot Platform Proposed Upgrading List